LRMR logo

LRMRLarimar Therapeutics Inc

$3.50
$0.13
(3.61%)
Today
Closed $3.47
$0.03
(0.86%)
After Hours
Updated: 06:58 PM EDT
Reported EarningsMay 14
Mkt Cap$373.98M
Vol1.56M

About

Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing treatments for patients suffering from complex rare diseases using a novel cell penetrating peptide technology platform. It also engages in the research, development, and commercialization of novel therapeutics for mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
71

Frequently Asked Questions

What is Market Cap of Larimar Therapeutics Inc?
What is the 52-week high for Larimar Therapeutics Inc?
What is the 52-week low for Larimar Therapeutics Inc?
What is Larimar Therapeutics Inc stock price today?
What was Larimar Therapeutics Inc stock price yesterday?
What is the PE ratio of Larimar Therapeutics Inc?
What is the Price-to-Book ratio of Larimar Therapeutics Inc?
What is the 50-day moving average of Larimar Therapeutics Inc?
How many employees does Larimar Therapeutics Inc have?